Korean biotech firm bought by Parataxis for Bitcoin treasury use
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Original Source
- Bitcoin price slips under $104K into 'triple witching' options expiry
- High risk, high reward: Crypto perpetual futures gain momentum in US
- The SEC’s staking guidance pivot is what tech-savvy regulation looks like
- Korean biotech firm bought by Parataxis for Bitcoin treasury use
- $330K Bitcoin block win: How one solo miner outsmarted the odds
- Crypto's true revolution is about humanity, not technology
- Bitcoin volume metric suggests '$130K-$135K BTC will happen' in the summer
- Here's when Bitcoin analysts expect new BTC price volatility
- There’s more to crypto crime than meets the eye: What you need to know
- The empire strikes out: Institutionalists failed to kill the stablecoin bill